We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » REORGANIZATION SET FOR CDER's OFFICE OF NEW DRUGS
REORGANIZATION SET FOR CDER's OFFICE OF NEW DRUGS
November 5, 2004
The FDA plans this spring to reorganize its divisions and offices that handle new drugs -- a move that could bring changes to who oversees drugmakers' products.